Diagnosis Groups | Author, year | Psychiatric Group | Notes | |||
---|---|---|---|---|---|---|
 |  | FRS [mean (SD)] | SCORE [mean (SD)] |  | ||
 |  | CVD | Stroke | CHD |  |  |
Bipolar disorder | Grover S, 2014 [54] | Â | Â | 3.4 (5.0) | 1.7 (1.8) | Â |
 | Slomka JM, 2012 [62] | 13.7 (10.0) |  |  |  |  |
 | Garcia-Portilla MP, 2009 [52] |  |  | 7.6 (7.4) | 1.8 (4.4) |  |
Depressive disorder | Acharya T, 2013 [43] | Â | Â | Â | Â | FRS (CHD) expressed by types of antidepressive medication groups. |
 | Allan CL, 2011 [22] |  | 10.3 (7.6) |  |  |  |
 | Hoffman BM, 2010 [55] | 14.0 (9.0) |  |  |  |  |
 | Smith PJ, 2007 [63] |  |  | 3.2 |  |  |
 | Zuidersma M, 2015 [66] | 5.8 (3.8) |  |  |  |  |
Schizophrenia | Bernardo M, 2009 [45] |  |  |  |  | SCORE: <1 %: 15.1 %; 1–4 %:68.8 %; 5–10 %: 6.1 %; 11–15 %:0.3 % and ≥15 %;0.1 % |
 | Daumit GL, 2008 [48] |  |  | 8.5 (7.4) |  |  |
 | Ferreira L, 2010 [51] |  |  |  |  | SCORE: no statistically significant difference between case and controls was observed. |
 | Goodrich DE, 2012 [53] |  |  |  |  | FRS (CVD): <10 %: 40.7 %, 10–20 %: 40.7 % and >20 %: 18.6 % |
 | Goff DC, 2005 [24] |  |  |  |  | FRS (CHD): In men: CATIE study: 9.4 (7.2); NHANES study: 7.0 (6.3) and in women: 6.3 (6.3) and 4.2 (4.5), respectively. |
 | McCreadie RG, 2003 [27] |  | 4.1 | 9.6 |  |  |
 | Nurjono M, 2014 [57] |  |  |  |  | FRS (CVD): Participants in the highest quartile of serum BDNF had a 3.3 times increased in FRS over those in the lowest quartile. |
 | Said MA, 2012 [59] |  |  | 6.3 (5.6) |  | 31.5 % of patients in the metabolic syndrome group had a high/very high FRS (CHD) vs. 11 % in non-metabolic syndrome group (p < 0.001) |
 | Tay YH, 2013 [29] | 4.7 (4.7) |  |  |  |  |
 | Protopopova D, 2012 [58] |  |  |  |  | SCORE ≥ 5 %: 10 % |
 | Arango C, 2008 [44] |  |  | 6.8 (6.9) | 0.9 (1.9) |  |
 | Cohn T, 2004 [37] |  |  |  |  | FRS (MI): 8.9 % in males, compared with control subjects (6.3) (p < 0.001) and 2.6 % females (vs. Control subjects 2.0 %) (p = 0.180). |
 | McLean G, 2014 [23] |  |  |  |  | Joint British Societies score: risk levels by age group and gender. Age was a major factor being identified as high risk (>20 %), with 79 % of those with schizophrenia aged 65–74 estimated at high risk compared with only 1.3 % of those aged 35–44. |
 | Ratliff JC, 2013 [28] | 10.7 |  |  |  |  |
 | Stroup TS, 2013 [60] |  |  | 7.3 (5.7) |  |  |
 | Sicras-Mainar A, 2013 [61] | 11.9 (5.7) |  |  |  |  |
SMI | Dickerson FB, 2013 [49] | Â | Â | Â | Â | FRS (CVD) in smokers 13.2 (11.9) and nonsmokers 7.4 (7.2) |
Druss BG, 2010 [50] | Â | Â | Â | Â | FRS (CHD): 6.9 for intervention and 9.8 for control group. | |
Foguet-Boreu Q, 2013 [32] |  |  |  |  | FRS (REGICOR): high (≥10 %): 4.6 % and SCORE: high (≥5 %): 5.4 % | |
Osborn DP, 2006 [36] |  |  |  |  | FRS (CHD): median: 5 % (IQR:2–12) | |
Psychiatric diagnoses | Wysokiński A, 2012 [65] | 6.4 (7.2) | 3.7 (2.8) | 5.8 (6.1) |  |  |
Correll CU, 2006 [46] | Â | Â | Â | Â | FRS (CHD): 8.29 (0.49) in men and 2.33 (0.52) in women. | |
Jin H, 2011 [56] | Â | Â | Â | Â | FRS (CHD) was increased by 79Â % in schizophrenia, 72Â % in posttraumatic stress disorder and 61Â % in mood disorder. | |
Mackin P, 2007 [25] | 11.3 (12.3) | 1.7 (3.2) | 9.3 (10.5) | Â | Â | |
Margari F, 2013 [26] | 8.3 (5.8) | Â | Â | Â | Â | |
Correll CU, 2011 [47] | Â | Â | 2.5 (4.2) | Â | Â | |
Taylor V, 2010 [64] | Â | Â | Â | Â | FRS (CHD) was lower for patients at baseline and follow-up, but increased across the follow-up period (2-years). Women patients showed an increase risk for CHD over time, and men did not. |